- South San Francisco CA, US Jason Gary Sagert - San Mateo CA, US Jonathan Alexander Terrett - Lexington MS, US Annie Yang Weaver - San Mateo CA, US Luc Roland Desnoyers - San Francisco CA, US Shweta Singh - Fremont CA, US
International Classification:
C07K 16/28 A61K 47/68 A61K 31/537
Abstract:
The invention relates generally to antibodies that bind CD166, activatable antibodies that specifically bind to CD166 and methods of making and using these anti-CD166 antibodies and anti-CD166 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
Anti-Cd71 Antibodies, Activatable Anti-Cd71 Antibodies, And Methods Of Use Thereof
- South San Francisco CA, US Kimberly Ann Tipton - San Francisco CA, US Jonathan Alexander Terrett - Lexington MA, US Shweta Singh - Fremont CA, US Annie Yang Weaver - San Mateo CA, US Luc Roland Desnoyers - San Francisco CA, US
The invention relates generally to antibodies that bind CD71, activatable antibodies that specifically bind to CD71 and methods of making and using these anti-CD71 antibodies and anti-CD71 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
Antibodies That Bind Activatable Antibodies And Methods Of Use Thereof
The invention relates generally to antibodies and antigen-binding fragments thereof that bind activatable antibodies and/or conjugated activatable antibodies and methods of making and using these antibodies that bind activatable antibodies and/or conjugated activatable antibodies.
Anti-Cd166 Antibodies, Activatable Anti-Cd166 Antibodies, And Methods Of Use Thereof
- South San Francisco CA, US Jason Gary Sagert - San Mateo CA, US Jonathan Alexander Terrett - Cupertino CA, US Annie Yang Weaver - San Mateo CA, US Luc Roland Desnoyers - San Francisco CA, US Shweta Singh - Fremont CA, US
International Classification:
C07K 16/28 A61K 31/537 A61K 47/48
Abstract:
The invention relates generally to antibodies that bind CD166, activatable antibodies that specifically bind to CD166 and methods of making and using these anti-CD166 antibodies and anti-CD166 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
Anti-Cd71 Antibodies, Activatable Anti-Cd71 Antibodies, And Methods Of Use Thereof
- South San Francisco CA, US Kimberly Ann Tipton - San Francisco CA, US Jonathan Alexander Terrett - Cupertino CA, US Shweta Singh - Fremont CA, US Annie Yang Weaver - San Mateo CA, US Luc Roland Desnoyers - San Francisco CA, US
International Classification:
C07K 16/28 A61K 39/395 A61K 49/00 A61K 47/48
Abstract:
The invention relates generally to antibodies that bind CD71, activatable antibodies that specifically bind to CD71 and methods of making and using these anti-CD71 antibodies and anti-CD71 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
Antibodies That Bind Activatable Antibodies And Methods Of Use Thereof
- SOUTH SAN FRANCISCO CA, US Tony W. Liang - San Mateo CA, US Annie Yang Weaver - San Mateo CA, US
International Classification:
A61K 51/10 C07K 16/42
Abstract:
The invention relates generally to antibodies and antigen-binding fragments thereof that bind activatable antibodies and/or conjugated activatable antibodies and methods of making and using these antibodies that bind activatable antibodies and/or conjugated activatable antibodies.